MedPath

Impact of a Carrier (Infection, Colonization) of Highly Bacteria Resistance on the Patient's Quality of Life Hospital Environment

Withdrawn
Conditions
Bacterial Infections
Interventions
Other: Quality of life questionnaire
Registration Number
NCT04226001
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

The quality of life of carriers detected infected or colonized by emerging highly resistant bacteria (BHRe) following the implementation of specific hygiene measures during the discovery of the microorganism has been little studied. To date, there have been no studies to determine the quality of life (QoL) in France of patients with hospitalized HBHRD.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age> 18 years old
  • Have a positive BHRe screening during the hospital stay and / or have a positive BHRe clinical sample during the hospital stay
  • Conscious patients
  • All types of stays in the hospital sector
  • All pathologies
Read More
Exclusion Criteria
  • Known patients with BHRe before hospitalization
  • PCH immediately upon admission (history of hospitalization abroad, patients contacted during a previous hospitalization)
  • Cognitive problem
  • Patients not proficient in French (requiring an interpreter)
  • Patients under guardianship
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
PatientsQuality of life questionnairePatients screened for carriers infected or colonized by emerging highly resistant bacteria.
Primary Outcome Measures
NameTimeMethod
Impact of the implementation of Complementary Hygiene Precautions following a carrier of emerging highly resistant bacteria on the quality of life of hospitalized patients12 months

Measurement of the decrease in utility corresponding to the deterioration of the QOL of patients since the implementation of the Additional Hygiene Precautions (PCH) following the discovery of their emerging highly resistant bacteria (BHRe).

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath